NVWM LLC’s Helus Pharma Inc. Common Stock HELP Stock Holding History

NVWM LLC’s Portfolio HELP Stock Details HELP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$725	Hold	59	–	–	﹤0.01%	677
2026 Q2	$390	Hold	59	–	–	﹤0.01%	705
2026 Q1	$283	Hold	59	–	–	﹤0.01%	682
2025 Q4	$483	Hold	59	–	–	﹤0.01%	654
2025 Q3	$346	Hold	59	–	–	﹤0.01%	617
2025 Q2	$495	Hold	59	–	–	﹤0.01%	596
2025 Q1	$374	Hold	59	–	–	﹤0.01%	592
2024 Q4	$520	Hold	59	–	–	﹤0.01%	552
2024 Q3	$525	Sell	59 -1	-2%	-$10	﹤0.01%	541
2024 Q2	$603	Hold	60	–	–	﹤0.01%	502
2024 Q1	$936	Hold	60	–	–	﹤0.01%	417
2023 Q4	$928	Buy	+60	New	+$1.12K	﹤0.01%	377

Other funds holding HELP

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

WIM

WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

KTC

Kentucky Trust Company Danville, Kentucky $200M AUM 22.53% 1-Year Est. Return

AAG

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

NVWM LLC's HELP Position: Q3 2026 in Review

NVWM LLC held its Helus Pharma Inc. Common Stock (HELP) position steady in Q3 2026 at 59 shares worth $725. The position accounts for ﹤0.01% of the portfolio, ranked #677.

NVWM LLC first reported a position in HELP in Q4 2023 and has held it in 12 quarters since. The position peaked at $936 in Q1 2024. 8 funds tracked by Wall St. Rank hold HELP as of Q3 2026.

NVWM LLC held 59 shares of Helus Pharma Inc. Common Stock worth $725 as of Q3 2026.
NVWM LLC left its Helus Pharma Inc. Common Stock share count unchanged in Q3 2026.
Helus Pharma Inc. Common Stock made up ﹤0.01% of NVWM LLC's portfolio in Q3 2026, its #677 holding.
NVWM LLC first reported a position in Helus Pharma Inc. Common Stock in Q4 2023 and has held it in 12 quarters since.
NVWM LLC's Helus Pharma Inc. Common Stock position peaked at $936 in Q1 2024.
8 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2026.

Based on NVWM LLC's 13F filing for Q3 2026, filed 14 Oct 2026.